Format

Send to

Choose Destination
Sci Rep. 2015 Sep 15;5:14148. doi: 10.1038/srep14148.

Dietary flavonoids, lignans and colorectal cancer prognosis.

Zamora-Ros R1, Guinó E2,3,4, Alonso MH2,3,4, Vidal C2,3,4, Barenys M3,5,6, Soriano A3,4,7, Moreno V2,3,4,6.

Author information

1
Biomarkers Group, Nutrition and Metabolism Section, International Agency for Research on Cancer (IARC), Lyon, France.
2
Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO).
3
Biomedical Research Institute of Bellvitge (IDIBELL).
4
CIBER en Epidemiologia y Salud Pública (CIBERESP), Barcelona, Spain.
5
Gastroenterology Service, Hospital de Viladecans, Barcelona, Spain.
6
Department of Clinical Sciences, Faculty of Medicine, University of Barcelona (UB), Barcelona, Spain.
7
Gastroenterology Service, University Hospital Bellvitge (HUB).

Abstract

Flavonoids and lignans are polyphenol classes with anticarcinogenic activities against colorectal cancer (CRC). However, very limited epidemiological evidence exists on their effects on CRC prognosis. This study aimed to evaluate the association between flavonoid and lignan intakes with the risk of CRC recurrence and overall survival in CRC patients. The study followed incident histologically confirmed CRC cases in Barcelona (Spain). Validated dietary questionnaires and lifestyle information were collected at recruitment. An ad hoc food composition database on flavonoids and lignans was compiled by using data from the US Department of Agriculture and Phenol-Explorer databases. Adjusted hazards ratios (HR) and 95% confidence intervals (CIs) were estimated using multivariable Cox models. After 8.6 years of mean follow-up, 133 of 409 (32.5%) participants died and 77 of 319 (24.1%) had a CRC recurrence. Total flavonoids were associated neither with CRC recurrence (HR comparing extreme tertiles 1.13, 95% CI 0.64-2.02; P-trend 0.67) nor with overall survival (HR(T3vsT1) 1.06, 95% CI 0.69-1.65; P-trend 0.78) in the multivariable models. No associations were also observed with either total lignans or any flavonoid subclass intake. In conclusion, the results of the current study do not support a role of flavonoid and lignan intake in the CRC prognosis.

PMID:
26369380
PMCID:
PMC4572925
DOI:
10.1038/srep14148
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center